# The Effect of Addition of Metformin In Obese Non- Diabetic Patients With Heart Failure With Preserved Ejection Fraction

> **NCT05847244** · PHASE2 · UNKNOWN · sponsor: **Sara ElAdawy** · enrollment: 80 (estimated)

## Conditions studied

- Diastolic Dysfunction
- Obesity

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT05847244
- **Lead sponsor:** Sara ElAdawy
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-10-01
- **Primary completion:** 2024-10-10
- **Final completion:** 2024-12-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05847244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05847244, "The Effect of Addition of Metformin In Obese Non- Diabetic Patients With Heart Failure With Preserved Ejection Fraction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05847244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*